Adherence is important to improving the health outcomes of patients with diabetes. Health technology and digital tools are just on way providers are encouraging patients to remain consistent with the treatment regimens.
Adherence is important to improving the health outcomes of patients with diabetes. Health technology and digital tools are just on way providers are encouraging patients to remain consistent with the treatment regimens.
Vivian Fonseca, MD, FRCP, a professor of medicine in the Endocrinology Department at Tulane University, for example, described recent findings surrounding a “diabetes remote monitoring system.” The automated health technology software not only promoted patient adherence to their medications, but to their appointments and other healthcare-related needs. While the technology didn’t help all patients, it generally showed to be cost-effective.
“We can effectively use this system on a fairly large scale. Once many patients are entered into the system, it becomes very cost-effective because the cost of the system remains static,” said Dr Fonesca. “With usual care, the more patients you see, the higher the cost in terms of seeing them in clinic and telephoning them for follow-up. Automated care therefore could produce some cost savings, which is important in healthcare reform. We want patients to have better outcomes, but it has to be in a cost-effective manner.”
Darwin Fogt, a physical therapist and founder of a company called eWellness, had similar outcomes with the utilization of health technology. His program also assisted providers and patients with the costs associated with diabetes management. Mr Fogt said that when combined together, telemedicine and physical therapy could prevent pre-diabetic patients’ conditions from worsening. Telemedicine, he argued, can reach a larger number of patients and engage them in making wiser decisions about their own healthcare. As with the monitoring program researched at Tulane, eWellness allows providers to remotely and digitally check-in with patients. Traditionally, providers or their staff perform patient care follow-ups in person or via the telephone. With technology such as mobile device applications, they can pinpoint patients who are most in need of an intervention.
“Our program could reach millions of people. If it can ensure compliance and adherence, we could make a big dent in the [future] diabetes population,” said Mr Fogt.
Around the Web
Remote Monitoring Could Be Cost-Effective in Diabetes Care [Medscape]
Entrepreneur Hopes Telemedicine + PT Will Stop Pre-Diabetes from Becoming Diabetes [MedCity News]
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Machine Learning Model Predicts Hepatocellular Carcinoma Risk in Patients With MASLD
March 22nd 2024Machine learning models have potential for early identification of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) who are at risk of hepatocellular carcinoma.
Read More
Examining Telehealth Uptake to Increase Equitable Care Access
January 26th 2023To mark the publication of The American Journal of Managed Care®’s 12th annual health IT issue, on this episode of Managed Care Cast, we speak with Christopher M. Whaley, PhD, health care economist at the RAND Corporation, who focuses on health economics issues, including the influence of the COVID-19 pandemic on health care delivery.
Listen
CMS is highly likely to negotiate the price of the obesity medication semaglutide in the coming years; many health care providers are trying to determine whether their cyberattack insurance will help cover their losses after the Change Healthcare hack; the US life expectancy increased for the first time in 2 years.
Read More
A global AIDS program that was in limbo for months got temporary relief after congressional negotiators agreed to a 1-year renewal in the next government funding package; the outcome of the November presidential election could determine the state of fetal tissue research in the US; federal officials and industry executives failed to make improvements that stop hacking attacks.
Read More